Kendine 91 | 943817-21-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: Kendine 91
• 英文别名: N-(5-(hydroxycarbamoyl)pentyl)-3-(4-methoxyphenyl)-5-phenyl 1H-pyrrole-2-carboxamide；N-[6-(hydroxyamino)-6-oxohexyl]-3-(4-methoxyphenyl)-5-phenyl-1H-pyrrole-2-carboxamide
• CAS: 943817-21-8
• 化学式: C₂₄H₂₇N₃O₄
• 分子量: 421.496
• InChiKey: XEUHFUCGFDCNQA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  31
• 可旋转键数：
  10
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  103
• 氢给体数：
  4
• 氢受体数：
  4

文献信息

• NEW HISTONE DEACETYLASE INHIBITORS BASED SIMULTANEOUSLY ON TRISUBSTITUTED 1H-PYRROLES AND AROMATIC AND HETEROAROMATIC SPACERS
  申请人：Cossío Mora Fernando Pedro

  公开号：US20120196885A1

  公开（公告）日：2012-08-02

  The present invention refers to compounds derived from trisubstituted 1H-pyrrole rings and aromatic rings, which have the following formula (I): wherein: R 1 and R 2 represent, independently, an optionally substituted C 6 -C 10 aryl radical or an optionally substituted heteroaryl radical; A and M represent, independently, a methylene group or a single bond, in which case the adjacent aromatic ring would be attached directly to the amide group; the Y═Z group represents together and indistinctly an oxygen atom, a sulfur atom, a cis-vinylidene group, an imino group, or a methine group with a sp 2 -hybridized carbon atom; X represents indistinctly a methine group, a cis-vinylidene group or a nitrogen atom; and W represents a hydroxyl group, an optionally substituted C 1 -C 6 alkyl group, an optionally substituted heteroaryl group or an optionally substituted C 6 -C 10 aryl group; or a salt, solvate or prodrug thereof, as well as to the process for their preparation and the use thereof for the treatment of cancer.

  本发明涉及从三取代的1H-吡咯环和芳香环衍生的化合物，其具有以下公式（I）： 其中： R1和R2分别表示一个可选择取代的C6-C10芳基基团或一个可选择取代的杂环基团； A和M分别表示一个亚甲基基团或一个单键，此时相邻的芳香环将直接连接到酰胺基团； Y═Z基团一起表示一个氧原子、硫原子、顺式-乙烯基团、亚胺基团或具有sp2杂化碳原子的甲基基团； X不明确地表示一个甲基基团、顺式-乙烯基团或一个氮原子； W表示一个羟基、一个可选择取代的C1-C6烷基基团、一个可选择取代的杂环基团或一个可选择取代的C6-C10芳基基团； 或其盐、溶剂合物或前药，以及其制备方法和用于治疗癌症的用途。
• [EN] HYDROXYPHENYL PYRROLE COMPOUNDS CONTAINING AN HYDROXAMIC ACID AS HDAC INHIBITORS AND MEDICINAL APPLICATIONS THEREOF<br/>[FR] COMPOSÉS HYDROXYPHÉNYL-PYRROLE CONTENANT UN ACIDE HYDROXAMIQUE, UTILISABLES EN TANT QU'INHIBITEURS DE HDAC ET LEURS APPLICATIONS MÉDICALES
  申请人：IKERCHEM S L

  公开号：WO2012136722A1

  公开（公告）日：2012-10-11

  The present invention refers to compounds derived from hydroxyphenyl 1H- pyrrole rings, which have the following formula (I): as well as to the procedure for their preparation, pharmaceutical compositions comprisingthe same and the use thereof for the treatment and/or prevention of a condition mediated by histone deacetylase such as cancer, hematological malignancies, autoimmune diseases, inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases and psychiatric disorders, cardiovascular diseases, endocrine and metabolic disorders, by inhibiting histone deacetylases and the therapeutic use of biological processes related to the mentioned inhibition.

  本发明涉及源自羟基苯基1H-吡咯环的化合物，其具有以下结构式（I）：以及它们的制备方法，包括相同的药物组合物，以及它们用于治疗和/或预防由组蛋白去乙酰化酶介导的疾病，如癌症、血液系统恶性肿瘤、自身免疫疾病、炎症性疾病、中枢神经系统疾病（如神经退行性疾病和精神障碍）、心血管疾病、内分泌和代谢紊乱，通过抑制组蛋白去乙酰化酶和与所述抑制有关的生物过程的治疗用途。
• Hydroxyphenyl pyrrole compounds containing an hydroxamic acid as hdac inhibitors and medicinal applications thereof
  申请人：Ikerchem, S.L.

  公开号：EP2508510A1

  公开（公告）日：2012-10-10

  The present invention refers to compounds derived from hydroxyphenyl 1H-pyrrole rings, which have the following formula (I): as well as to the procedure for their preparation, pharmaceutical compositions comprising the same and the use thereof for the treatment and/or prevention of a condition mediated by histone deacetylase such as cancer, hematological malignancies, autoimmune diseases, inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases and psychiatric disorders, cardiovascular diseases, endocrine and metabolic disorders, by inhibiting histone deacetylases and the therapeutic use of biological processes related to the mentioned inhibition.

  本发明涉及从羟基苯基1H-吡咯环衍生的化合物，其具有以下公式（I）：以及其制备方法，包括相同成分的药物组合物以及用于治疗和/或预防由组蛋白去乙酰化酶介导的病症，如癌症、血液恶性肿瘤、自身免疫疾病、炎症性疾病、中枢神经系统（CNS）疾病如神经退行性疾病和精神障碍、心血管疾病、内分泌和代谢紊乱，通过抑制组蛋白去乙酰化酶和与所述抑制相关的生物过程的治疗用途。
• HYDROXYPHENYL PYRROLE COMPOUNDS CONTAINING AN HYDROXAMIC ACID AS HDAC INHIBITORS AND MEDICINAL APPLICATIONS THEREOF
  申请人：Cossío Mora Fernando Pedro

  公开号：US20150038545A1

  公开（公告）日：2015-02-05

  The present invention refers to compounds derived from hydroxyphenyl 1H-pyrrole rings, which have the following formula (I): as well as to the procedure for their preparation, pharmaceutical compositions comprising the same and the use thereof for the treatment and/or prevention of a condition mediated by histone deacetylase such as cancer, hematological malignancies, autoimmune diseases, inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases and psychiatric disorders, cardiovascular diseases, endocrine and metabolic disorders, by inhibiting histone deacetylases and the therapeutic use of biological processes related to the mentioned inhibition.

  本发明涉及从羟基苯基1H-吡咯环衍生的化合物，其具有以下式子（I）： 同时，本发明还涉及其制备方法、包含相同化合物的药物组合物以及将其用于治疗和/或预防由组蛋白去乙酰化酶介导的疾病，如癌症、血液恶性肿瘤、自身免疫疾病、炎症性疾病、中枢神经系统（CNS）疾病，如神经退行性疾病和精神障碍、心血管疾病、内分泌和代谢性疾病，通过抑制组蛋白去乙酰化酶和与所述抑制相关的生物过程的治疗用途。
• New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers
  申请人：Ikerchem, S.L.

  公开号：EP2305643A1

  公开（公告）日：2011-04-06

  The present invention refers to compounds derived from trisubstituted 1H-pyrrole rings and aromatic rings, which have the following formula (I): as well as to the procedure for their preparation and the use thereof for the treatment of cancer by inhibiting histone deacetylases and the therapeutic use of biological processes related to the mentioned inhibition.

  本发明指的是由三取代的 1H 吡咯环和芳香环衍生的化合物，它们具有下式 (I)： 以及它们的制备方法和通过抑制组蛋白去乙酰化酶治疗癌症的用途，以及与上述抑制有关的生物过程的治疗用途。